Clearpoint Prism Neuro Laser Therapy System To Receive FDA Clearance

FDA approves ClearPoint Prism Neuro Laser Therapy System.

FREMONT, CA: “Over the past decade, the ClearPoint Neuro Navigation System has offered an efficient one-room solution to assist neurosurgeons in the United States and Europe to accurately place laser fibers and help treat brain tumors, radiation necrosis, and epileptic foci in thousands of patients," says Joe Burnett, President, and CEO of ClearPoint Neuro. Clinical Laserthermia Systems (CLS), a Swedish partner of ClearPoint Neuro, has been granted 510(k) clearance for its laser, which the Company plans to commercialize as the ClearPoint Prism" Neuro Laser Therapy System. ClearPoint Neuro is a global therapy-enabling platform company providing navigation and delivery to the brain.

“We look forward to leading the expansion of laser therapy treatment options for patients and neurosurgeons in the United States and beyond in the coming years. This is another example of the innovation that ClearPoint is delivering to the neurosurgery and spine community through our team and our expert partners,” adds Burnett.